Tau pathology associates with in vivo cortical thinning in Lewy body disorders

OBJECTIVES: To investigate the impact of Alzheimer’s disease (AD) co‐pathology on an in vivo structural measure of neurodegeneration in Lewy body disorders (LBD). METHODS: We studied 72 LBD patients (Parkinson disease (PD) = 2, PD‐MCI = 25, PD with dementia = 10, dementia with Lewy bodies = 35) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Spotorno, Nicola, Coughlin, David G., Olm, Christopher A., Wolk, David, Vaishnavi, Sanjeev N., Shaw, Leslie M., Dahodwala, Nabila, Morley, James F., Duda, John E., Deik, Andres F., Spindler, Meredith A., Chen‐Plotkin, Alice, Lee, Edward B., Trojanowski, John Q., McMillan, Corey T., Weintraub, Daniel, Grossman, Murray, Irwin, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732256/
https://www.ncbi.nlm.nih.gov/pubmed/33108692
http://dx.doi.org/10.1002/acn3.51183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732256/
https://www.ncbi.nlm.nih.gov/pubmed/33108692
http://dx.doi.org/10.1002/acn3.51183

Ejemplares similares